Singapore markets closed

Fractyl Health, Inc. (GUTS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
6.19-0.03 (-0.48%)
At close: 04:00PM EDT
6.21 +0.02 (+0.32%)
After hours: 07:57PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 296.37M
Enterprise value 349.55M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.46k
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-51.83%
S&P500 52-week change 326.27%
52-week high 314.50
52-week low 35.75
50-day moving average 37.16
200-day moving average 37.69

Share statistics

Avg vol (3-month) 3315.83k
Avg vol (10-day) 3132.4k
Shares outstanding 547.88M
Implied shares outstanding 648.11M
Float 819.05M
% held by insiders 14.29%
% held by institutions 163.53%
Shares short (30 Apr 2024) 43.23M
Short ratio (30 Apr 2024) 413.97
Short % of float (30 Apr 2024) 416.81%
Short % of shares outstanding (30 Apr 2024) 46.76%
Shares short (prior month 28 Mar 2024) 43.43M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-185,442.86%

Management effectiveness

Return on assets (ttm)-46.33%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)120k
Revenue per share (ttm)0.06
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -50.55M
Net income avi to common (ttm)-94.27M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)33.21M
Total cash per share (mrq)0.69
Total debt (mrq)86.39M
Total debt/equity (mrq)N/A
Current ratio (mrq)3.19
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-42.82M
Levered free cash flow (ttm)-23.26M